Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine

References

• Cowie CC Rust KF Ford ES Eberhardt MS Byrd-Holt DD Li C Full accounting of diabetes and pre-diabetes in the US population in 1988–1994 and 2005–2006 Diabetes Care 2009 32 287 294 19017771
   PubMed Web of Science ®Google Scholar
• Gaster B Hirsch IB The effects of improved glycemic control on complications in type 2 diabetes Arch Int Med 1998 158 134 140 9448551
   PubMed Web of Science ®Google Scholar
• Ziegler D Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 2008 31 Suppl 2 S255 S261 18227494
   PubMed Web of Science ®Google Scholar
• Armstrong DG Chappell AS Le TK Kajdasz DK Backonja M D’Souza DN Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes Pain Med 2007 8 410 418 17661854
   PubMed Web of Science ®Google Scholar
• Iyengar S Webster AA Hemrick-Luecke SK Xu JY Simmons RM Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats J Pharmacol Exp Ther 2004 311 576 584 15254142
   PubMed Web of Science ®Google Scholar
• Raskin J Pritchett YL Wang F D’Souza DN Waninger AL Iyengar S A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain Pain Med 2005 6 346 356 16266355
   PubMed Web of Science ®Google Scholar
• Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus JAMA 2002 287 2563 2569 12020338
   PubMed Web of Science ®Google Scholar
• Wong MC Chung JW Wong TK Effects of treatments for symptoms of painful diabetic neuropathy: systematic review BMJ 2007 335 87 17562735
   PubMed Web of Science ®Google Scholar
• Smith AG Russell JW Feldman EL Goldstein J Peltier A Smith S Lifestyle intervention for prediabetic neuropathy Diabetes Care 2006 29 1294 1299 16732011
   PubMed Web of Science ®Google Scholar
• Gaede P Vedel P Parving HH Pedersen O Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study Lancet 1999 353 617 622 10030326
   PubMed Web of Science ®Google Scholar
• Quilici S Chancellor J Lothgren M Simon D Said G Le TK Meta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain BMC Neurol 2009 9 6 19208243
   PubMed Web of Science ®Google Scholar
• Beard SM McCrink L Le TK Garcia-Cebrian A Monz B Malik RA Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK Curr Med Res Opin 2008 24 385 399 18157921
   PubMed Web of Science ®Google Scholar
• Westanmo AD Gayken J Haight R Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor Am J Health Syst Pharm 2005 62 2481 2490 16303903
   PubMed Web of Science ®Google Scholar
• Max MB Lynch SA Muir J Shoaf SE Smoller B Dubner R Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy N Engl J Med 1992 326 1250 1256 1560801
   PubMed Web of Science ®Google Scholar
• Wernicke JF Pritchett YL D’Souza DN Waninger A Tran P Iyengar S A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain Neurology 2006 67 1411 1420 17060567
   PubMed Web of Science ®Google Scholar
• Ginsberg DL Venlafaxine Effective for Painful Polyneuropathy Prim Psychiatry 2003 10 41
   Google Scholar
• Sultan A Gaskell H Derry S Moore RA Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials BMC Neurol 2008 8 29 18673529
   PubMed Web of Science ®Google Scholar
• Whitmyer VG Dunner DL Kornstein SG Meyers AL Mallinckrodt CH Wohlreich MM A comparison of initial duloxetine dosing strategies in patients with major depressive disorder J Clin Psychiatry 2007 68 1921 1930 18162024
   PubMed Web of Science ®Google Scholar
• Goldstein DJ Lu Y Detke MJ Hudson J Iyengar S Demitrack MA Effects of duloxetine on painful physical symptoms associated with depression Psychosomatics 2004 45 17 28 14709757
   PubMed Web of Science ®Google Scholar
• Goldstein DJ Lu Y Detke MJ Lee TC Iyengar S Duloxetine vs. placebo in patients with painful diabetic neuropathy Pain 2005 116 109 118 15927394
   PubMed Web of Science ®Google Scholar
• Ghoniem GM Van Leeuwen JS Elser DM Freeman RM Zhao YD Yalcin I A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence J Urol 2005 173 1647 1653 15821528
   PubMed Web of Science ®Google Scholar
• Russell JW Duloxetine in painful diabetic neuropathy Nat Clin Pract Neurol 2006 2 18 19 16932514
   PubMedGoogle Scholar
• Skljarevski V Desaiah D Zhang Q Chappell AS Detke MJ Gross JL Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain Diabetes Metab Res Rev 2009 [Epub ahead of print]
   Web of Science ®Google Scholar
• Farrar JT Young JPJr LaMoreaux L Werth JL Poole RM Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 2001 94 149 158 11690728
   PubMed Web of Science ®Google Scholar
• Pritchett YL McCarberg BH Watkin JG Robinson MJ Duloxetine for the management of diabetic peripheral neuropathic pain: response profile Pain Med 2007 8 397 409 17661853
   PubMed Web of Science ®Google Scholar
• Ziegler D Pritchett YL Wang F Desaiah D Robinson MJ Hall JA Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain Diabetes Care 2007 30 664 669 17327338
   PubMed Web of Science ®Google Scholar
• Wernicke JF Wang F Pritchett YL Smith TR Raskin J D’Souza DN An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain Pain Med 2007 8 503 513 17716324
   PubMed Web of Science ®Google Scholar
• Raskin J Wang F Pritchett YL Goldstein DJ Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study Pain Med 2006 7 373 385 17014595
   PubMed Web of Science ®Google Scholar
• Wohlreich MM Acharya N Strombom I Kuritzky L Robinson M Heinloth AN Answers to the most common questions about the hepatic safety profile of duloxetine Postgrad Med 2008 120 111 118 18654076
   PubMed Web of Science ®Google Scholar
• Kroenke K Krebs EE Bair MJ Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews Gen Hosp Psychiatry 2009 31 206 219 19410099
   PubMed Web of Science ®Google Scholar
• O’Connor AB Noyes K Holloway RG A cost-utility comparison of four first-line medications in painful diabetic neuropathy Pharmaco-economics 2008 26 1045 1064
   Web of Science ®Google Scholar
• Murad MH Smith SA Review: tricyclic antidepressants, anticonvulsants, opioids, and capsaicin cream are effective treatments for diabetic neuropathy ACP J Club 2008 148 2 18170989
   PubMedGoogle Scholar
• Rosenstock J Tuchman M LaMoreaux L Sharma U Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 2004 110 628 638 15288403
   PubMed Web of Science ®Google Scholar
• Lesser H Sharma U LaMoreaux L Poole RM Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Neurology 2004 63 2104 2110 15596757
   PubMed Web of Science ®Google Scholar
• Freynhagen R Strojek K Griesing T Whalen E Balkenohl M Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens Pain 2005 115 254 263 15911152
   PubMed Web of Science ®Google Scholar
• Richter RW Portenoy R Sharma U LaMoreaux L Bockbrader H Knapp LE Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial J Pain 2005 6 253 260 15820913
   PubMed Web of Science ®Google Scholar
• Tolle T Freynhagen R Versavel M Trostmann U Young JPJr Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study Eur J Pain 2008 12 203 213 17631400
   PubMed Web of Science ®Google Scholar